| Caleb Tyler Leach, CRNA | |
|
1030 River Oaks Dr, Flowood, MS 39232-9553 | |
| (601) 490-0492 | |
| Not Available |
| Full Name | Caleb Tyler Leach |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 1030 River Oaks Dr, Flowood, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588315238 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 901756 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mississippi Baptist Medical Center | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Perioperative Services Of Mississippi, Llc | 8921365255 | 93 |
News Archive
Women die and get infections more often than men after heart surgery because they tend to receive more blood transfusions, which boost the risks of bad outcomes, according to a study published in the December Journal of Women's Health.
The U.S. Food and Drug Administration, the Centers for Disease Control and Prevention and the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) will host a joint public workshop on how best to measure progress in reducing foodborne illnesses on March 30, in Washington, D.C.
BIOTRONIK AG, a leading manufacturer of vascular interventional devices, announced the introduction of a line extension to its popular 4 F compatible, self-expanding stent system dedicated for the treatment of long disease segments in the superficial femoral artery (SFA) and infrapopliteal arteries.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance on monoclonal antibody ICT-69 which targets multiple myeloma and ovarian cancers. The antibody has demonstrated high specificity to these cancers by targeting a novel cell surface antigen.
› Verified 1 days ago
| Entity Name | Anesthesia Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750300836 PECOS PAC ID: 4486637881 Enrollment ID: O20040608000711 |
News Archive
Women die and get infections more often than men after heart surgery because they tend to receive more blood transfusions, which boost the risks of bad outcomes, according to a study published in the December Journal of Women's Health.
The U.S. Food and Drug Administration, the Centers for Disease Control and Prevention and the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) will host a joint public workshop on how best to measure progress in reducing foodborne illnesses on March 30, in Washington, D.C.
BIOTRONIK AG, a leading manufacturer of vascular interventional devices, announced the introduction of a line extension to its popular 4 F compatible, self-expanding stent system dedicated for the treatment of long disease segments in the superficial femoral artery (SFA) and infrapopliteal arteries.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance on monoclonal antibody ICT-69 which targets multiple myeloma and ovarian cancers. The antibody has demonstrated high specificity to these cancers by targeting a novel cell surface antigen.
› Verified 1 days ago
| Entity Name | Perioperative Services Of Mississippi, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881123123 PECOS PAC ID: 8921365255 Enrollment ID: O20171122000010 |
News Archive
Women die and get infections more often than men after heart surgery because they tend to receive more blood transfusions, which boost the risks of bad outcomes, according to a study published in the December Journal of Women's Health.
The U.S. Food and Drug Administration, the Centers for Disease Control and Prevention and the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) will host a joint public workshop on how best to measure progress in reducing foodborne illnesses on March 30, in Washington, D.C.
BIOTRONIK AG, a leading manufacturer of vascular interventional devices, announced the introduction of a line extension to its popular 4 F compatible, self-expanding stent system dedicated for the treatment of long disease segments in the superficial femoral artery (SFA) and infrapopliteal arteries.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance on monoclonal antibody ICT-69 which targets multiple myeloma and ovarian cancers. The antibody has demonstrated high specificity to these cancers by targeting a novel cell surface antigen.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Caleb Tyler Leach, CRNA 189 Stone Creek Dr, Madison, MS 39110-5058 Ph: (601) 490-0492 | Caleb Tyler Leach, CRNA 1030 River Oaks Dr, Flowood, MS 39232-9553 Ph: (601) 490-0492 |
News Archive
Women die and get infections more often than men after heart surgery because they tend to receive more blood transfusions, which boost the risks of bad outcomes, according to a study published in the December Journal of Women's Health.
The U.S. Food and Drug Administration, the Centers for Disease Control and Prevention and the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) will host a joint public workshop on how best to measure progress in reducing foodborne illnesses on March 30, in Washington, D.C.
BIOTRONIK AG, a leading manufacturer of vascular interventional devices, announced the introduction of a line extension to its popular 4 F compatible, self-expanding stent system dedicated for the treatment of long disease segments in the superficial femoral artery (SFA) and infrapopliteal arteries.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance on monoclonal antibody ICT-69 which targets multiple myeloma and ovarian cancers. The antibody has demonstrated high specificity to these cancers by targeting a novel cell surface antigen.
› Verified 1 days ago
Dr. Merrill D Hardy Jr., M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2550 Flowood Dr, Suite 400, Flowood, MS 39232 Phone: 601-933-9521 Fax: 601-933-9525 | |
Dr. Constantine P Zouboukos, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2550 Flowood Dr, Suite 400, Flowood, MS 39232 Phone: 601-933-9521 Fax: 601-933-9525 | |
Thomas D Buford, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 120 Stone Creek Blvd Ste 500, Flowood, MS 39232 Phone: 601-420-2040 Fax: 601-420-2356 | |
Sarah H Hines, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1026 N Flowood Dr, Flowood, MS 39232 Phone: 601-936-0681 Fax: 601-936-0686 | |
Dr. Lee E Herring, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2550 Flowood Dr, Suite 400, Flowood, MS 39232 Phone: 601-933-9521 Fax: 601-933-9525 | |
Billie W. Bruner, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1026 N Flowood Dr, Flowood, MS 39232 Phone: 601-936-0681 Fax: 601-936-0686 | |
Dr. Stephen R Snypes, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2550 Flowood Dr, Suite 400, Flowood, MS 39232 Phone: 601-933-9521 Fax: 601-933-9525 |